Bold Capital Enterprises Ltd and Dymedso Inc., a Montréal-based medical technology company, announced recently that 12 healthcare institutions in Quebec are now permitted to provide their patients with the benefits of a new, state-of-the-art device that uses acoustic sound waves for the treatment of lung disorders and respiratory infections, including those related to COVID-19. Dr. Simon Phaneuf, an emergency physician and Chief Scientific Officer at Dymedso and company founder Yvon Robert join me to provide more insight into this interesting development. For more information on how to get one of these machines (they can be used at home), log on to https://www.dymedso.com.